title: Endogenous opioid peptides and blood pressure regulation during controlled, stepwise hemorrhagic hypotension.
abstract: In the present study, the role of the endogenous opioid peptide systems in the regulation of blood pressure during standardized, stepwise hemorrhagic hypotension was investigated in anesthetized rats. Central as well as peripheral administration of naloxone resulted in an increase in the bleeding volumes required to reduce blood pressure. Bleeding volumes also increased after the peripheral injection of naloxone methobromide, an analog of naloxone that does not readily cross the blood-brain barrier. Following central administration of antisera against beta- and alpha-endorphin and dynorphin A(1-13), the amount of blood that had to be withdrawn to induce hypotension was elevated. In rats treated with an antiserum against [Met5] enkephalin or gamma-endorphin, bleeding volumes did not differ from those of rats treated with control serum. These data indicate that activation of central and possibly also of peripheral opiate receptors plays a role in the control of blood pressure during blood loss. Dynorphin A(1-13), beta- and alpha-endorphin, or closely related peptides might be the endogenous ligands for the receptors that are blocked by naloxone.
authors.affiliation: Rudolf Magnus Institute for Pharmacology, Medical Faculty, State University of Utrecht, The Netherlands.
authors.forename: M H
authors.initials: MH
authors.lastname: van den Berg
authors.forename: P L
authors.initials: PL
authors.lastname: van Giersbergen
authors.forename: J
authors.initials: J
authors.lastname: Cox-van Put
authors.forename: W
authors.initials: W
authors.lastname: de Jong
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D004399:Dynorphins / Q000276:immunology / Q000502:physiology; D004723:Endorphins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology*; D004744:Enkephalin, Methionine / Q000276:immunology / Q000502:physiology; D006470:Hemorrhage / Q000150:complications*; D007022:Hypotension / Q000209:etiology / Q000503:physiopathology*; D007116:Immunization, Passive; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010111:Oxymorphone / Q000494:pharmacology; D010446:Peptide Fragments / Q000276:immunology / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D018822:alpha-Endorphin; D001615:beta-Endorphin / Q000276:immunology / Q000502:physiology; D018823:gamma-Endorphin
chemical_list: D004723:Endorphins; D010446:Peptide Fragments; D009270:Naloxone; D004744:Enkephalin, Methionine; D001615:beta-Endorphin; D018822:alpha-Endorphin; D018823:gamma-Endorphin; C026843:dynorphin (1-13); D004399:Dynorphins; D010111:Oxymorphone